← FDA Drug Approvals (Drugs@FDA)

EXEMESTANE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2017-03-10

Drug application

FDA Application #
ANDA203315
Application type
Abbreviated New Drug Application (Generic)
Brand name
EXEMESTANE
Generic name
Exemestane
Active ingredients
EXEMESTANE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
RISING
First approval
2017-03-10

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown